# OnCo record oleclumab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/oleclumab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "oleclumab" ;
  schema:name "Oleclumab"@en ;
  schema:description "Oleclumab is an experimental investigational agent whose form is not stated in the registry from AstraZeneca in phase 3 trials for non-small-cell lung cancer, triple-negative breast cancer and colorectal cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/oleclumab/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=MEDI9447>, <https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleclumab> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "antibody (INN stem -mab; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/colorectal/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:trials <https://onco.cc/trials/nct05221840/>, <https://onco.cc/trials/nct06606847/>, <https://onco.cc/trials/nct04068610/>, <https://onco.cc/trials/nct05061550/>, <https://onco.cc/trials/nct03381274/>, <https://onco.cc/trials/nct03742102/> .